respiratory syncytial virus (rsv) vaccine (recombinant adjuvanted)

Italy

Drugs containing this active substance

  • AREXVY

    It is a vaccine that helps protect adults aged 18 and older against respiratory syncytial virus (RSV), a virus that can cause lung infections or worsen pre-existing respiratory and heart diseases.

    Form: powder and suspension for injectable suspension

    Active substance Dosage
    respiratory syncytial virus (rsv) vaccine (recombinant adjuvanted) -

    ATC: J07BX05

    Manufacturer: GLAXOSMITHKLINE BIOLOGICALS S.A.